Telix upgraded on FY outlook as analysts publish bullish notes
MELBOURNE: Investors swarmed to ASX-listed Telix Pharmaceuticals after its first-quarter revenue jumped 62 per cent and
MELBOURNE: Investors swarmed to ASX-listed Telix Pharmaceuticals after its first-quarter revenue jumped 62 per cent and